A historic shift in Canadian drug policy has happened, as the regulators allow the use of psilocybin fungi for therapeutic applications. Previously, these substances were severely restricted, but a mounting body of research suggests they may offer relief for mental health illnesses like PTSD. This change represents a key step toward rethinking the